The team at ERS is excited to participate in-person at this year’s 2022 NCRA Conference, April 6-9, 2022! If you aren’t able to visit in person, you can also find us in the Virtual Exhibit Hall!
Please plan on stopping by our booth to learn more about ERS and our cancer registry management solution, CRStar, and how we can help your registry become an integral part of the patient journey at your cancer center … and more!
We’d also love to talk to you about our ongoing partnerships with HLA-Global and OncoLens – partnerships that will help your registry become an integral part of the patient journey at your cancer center!
This year we are giving away a COACH Day Tote! Ask one of our booth representatives how you can sign up for our Raffle. Online participants can also sign up by visiting our virtual booth!
|
|
|
Clinical Corner
Frederick L. Greene, MD, FACS, CMO
|
Each year we frequently hear that a word, color, or child’s name is chosen as the leading example and most frequently used in each of these categories. It is certainly true that when it comes to “cancer theories” over the last two or three years, the term “microbiome” is the winner.
The concept is that the bacteria in our gastrointestinal (GI) tract play a major role in the development of a variety of malignancies. The microbiome has also been shown to modulate anticancer drug efficacy. Altered gut microbiota are associated with resistance to chemotherapy drugs and immune checkpoint inhibitors while supplementation of distinct bacterial species restores responses to anticancer drugs.
Accumulating evidence has revealed the potential of modulating the gut microbiota to enhance the efficacy of anticancer drugs. Regardless of the valuable findings by preclinical models and clinical data of patients with cancer, a more thorough understanding of the interactions of the microbiota with cancer therapy helps researchers identify novel strategies for cancer prevention, stratify patients for more effective treatment and reduce treatment complications.
Gut microbiota are also linked to cancer through increasing inflammation in the GI tract. The key is to unlock the mechanisms used by distinct bacterial species to modulate cancer growth, alter immune responses and modify the efficacy of chemotherapeutic drugs. The ultimate challenge is to regulate the gut microbiota to achieve both prevention and treatment strategies for a number of cancers such as colon, gastric and pancreatic malignancy.
While the makeup of the “microbiome” of patients with cancer is not currently captured in our cancer registries, the acquisition of these data may be a future key to unraveling the role of gut bacteria as a precursor of clinical cancer diagnoses. Stay tuned!
|
|
|
|
Save the Date for an Educational Webinar! |
|
Save the date for our upcoming educational webinar, Cancer Registry Data: Hidden Gem of Healthcare. This one hour webinar will be presented by Barbara Dearmon, Manager, Oncology Support Services at St. Vincent's Jacksonville, and Catherine Bieker, Director, System Cancer Registry for SCL Health. Amy Arnold, BA, CTR, Manager, Strategic Services for ERS, will moderate the presentation.
The webinar is at noon EST on Tuesday, May 17, 2022 with an encore presentation at noon EST on Thursday, May 19, 2022, and will focus on promoting the use of cancer registry data, how cancer registry data can be utilized to support hospital administration, how to determine referral patterns and how this can help facilities look for growth opportunities, and utilizing registry data to support NAPBC program w/ BPL audits
Invitations will be emailed to clients on Tuesday, May 3, 2022. This webinar has been approved for 1 CEU by NCRA.
|
|
|
Make ERS part of your Fall Conference |
|
Is your state looking for speakers for it's fall conference? State cancer registry associations are in the planning stages of fall educational conferences and we would love to help!
Let our team, which includes Dr. Frederick L. Greene, CMO, and Amy Arnold, Manager, Strategic Services, bring their decades of registry expertise, knowledge and experience to your team as speakers on various topics.
Topics include Edit Enlightenment: Conquering GenEdits and Metafiles, 100 Years of the Commission on Cancer: Implications for Cancer Registrars and Registries, and Automated Data Exchange: Approaches to Revitalize your Cancer Registry. Our speakers can also customize a topic just for your organization, such as cancer site specific topics.
Our speakers can present virtually or in person at your conference, meeting, educational session and more! Click the link below to learn more about the ERS Speakers Bureau.
|
|
|
ERS joins all cancer registrars in celebration of National Cancer Registrars Week - April 4-8, 2022!
Cancer registrars play a pivotal role in capturing and analyzing the data that drives prevention, research, treatment, and outcome initiatives that directly impact the quality and outcomes of patient care. Administrators and clinicians have come to rely on the cancer registry as “the driving force of cancer data!”
We salute your hard work, commitment, and dedication!
|
|
|
Care to be Aware!
Cyber Security Tips
|
Although it might be common sense, if asked where your PHI resides in the cancer registry database, the areas where all the PHI resides is actually much more significant than one would think. As part of protecting PHI, it's essential to know where your PHI exists.
For example, it's easy to identify the PHI fields on the patient screen - last name, first name, DOB, SSN, address, etc. - but consider other areas in the abstract where PHI can potentially reside, such as in a secondary next of kin contact, or somewhere buried in one of your many text fields. In a more extreme example, in the usual occupation field, where the mention of a CEO of a small business with a very unique and searchable name can lead to the discovery of an individual's PHI.
All of these potential locations serve as a reminder to consider PHI each time that you run a report for a physician, for tumor board, and for the many other areas you are asked to provide data for. Some PHI reporting to these groups is part of your normal process. But being aware of all potential areas where PHI resides will help you do your part to lock it down.
|
|
|
|
Do you love CRStar?
So do we and we are offering our loyal customers the chance to earn a $200 gift card when a Cancer Program that you refer becomes an ERS customer!
Please click "Refer CRStar" below if you know of any Cancer Programs that could benefit from CRStar and the advantages that CRStar users enjoy and rely on.
Let's grow our CRStar community together!
Terms and conditions can be found on the CRStar Referral Form.
|
|
|
|
ERS, Inc. | www.mycrstar.com |
|
|
|
|
|
|
